Dual Role of Cancer Epithelial-Specific TRAF3 in Regulating Breast Cancer Cell Survival and Lymphocyte Activity
International Journal of Molecular Sciences · 15.05.2026 · 27 (10) · 4414
DOI: 10.3390/ijms27104414 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.05.2026. Verfasst von Chaido Sirinian und 13 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Laboratory, Division of Oncology, Department of Medicine, University of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: TNF Receptor-Associated Factor 3, Breast Neoplasms, Lymphocytes. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HELLENIC SOCIETY OF MEDICAL ONCOLOGY, Hellenic Society for Molecular Medicine and Personalized Diagnostics and Treatment, the National Recovery and Resilience Plan "Greece 2.0" - Next Generation EU Grant.
Abstract (Originalsprache)
TRAF3 (TNF Receptor Associated Factor 3) is a regulator of NF-κB signaling, acting mainly as an inhibitor of the alternative NF-κB pathway. While TRAF3 has a well-established role in immune function, mainly via B- and T-lymphocyte regulation, its roles in cancer remain unclear. Breast cancer is the most common malignancy in women and a neoplasm displaying high levels of intratumoral heterogeneity. Identifying and understanding key molecules at the interface of breast cancer cells and the immune system is crucial for advancing therapeutic strategies for breast cancer patients. Here, by employing publicly available breast cancer datasets, breast cancer cell lines stably expressing TRAF3, mass spectrometry analysis in combination with functional assays, co-culture systems, and signal pathway characterization, we sought to assess the specific role of TRAF3 in breast cancer cells and how TRAF3-expressing breast cancer cells affect their immune microenvironment. Our results indicate that TRAF3 protein overexpression inhibits colony formation through apoptosis regulation. Proteome analysis for TRAF3 interactors and over-representation analysis identified multiple protein complexes related to cell cycle, apoptosis, and immune responses. Furthermore, TRAF3-expressing breast cancer cells displayed reduced levels of PD-L1 and when co-cultured with PBMCs induced a pro-inflammatory profile with increased CD16-NK cells and higher levels of IFN-γ and TNF-α and lower IL-10 and Tregs in the culture. These findings further expand the role of TRAF3 in breast cancer, not only as a regulator of EMT and survival of cancer cells, but also as a modulator of the tumor-immune microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Oncology Laboratory, Division of Oncology, Department of Medicine, University of Patras, 26504 Patras, Greece.
- Laboratory of Immunohematology, Department of Internal Medicine, Medical School, University of Patras, 26504 Patras, Greece.
- Department of Nursing, School of Health Rehabilitation Sciences, University of Patras, 26504 Patras, Greece.
- Department of Biomedical Sciences, University of West Attica, 12243 Athens, Greece.
- Protein Chemistry Facility, Biomedical Sciences Research Center "Alexander Fleming", 16672 Athens, Greece.
- Breast Unit, Department of Surgery, University Hospital of Patras, 26504 Patras, Greece.
ORCID-Profile: Anne-Lise de Lastic, Martina Samiotaki, Maria Ioanna Argentou, Søren E Degn
Förderung
- HELLENIC SOCIETY OF MEDICAL ONCOLOGY
- Hellenic Society for Molecular Medicine and Personalized Diagnostics and Treatment
- the National Recovery and Resilience Plan "Greece 2.0" - Next Generation EU Grant
- National Recovery and Resilience Plan “Greece 2.0”—Next Generation EU
Zitieren
APA
Sirinian, C., de Lastic, A. L., Zaverdas, H., Nifora, M., Georgakopoulou, D., Samiotaki, M., Argentou, M. I., Peroukidis, S., Degn, S. E., Rusan, M., Theofilatos, K., Mavroudi, S., Papanastasiou, A. D., & Koutras, A. (2026). Dual Role of Cancer Epithelial-Specific TRAF3 in Regulating Breast Cancer Cell Survival and Lymphocyte Activity. International Journal of Molecular Sciences, 27(10), 4414. https://doi.org/10.3390/ijms27104414
Vancouver
Sirinian C, de Lastic AL, Zaverdas H, Nifora M, Georgakopoulou D, Samiotaki M, et al. Dual Role of Cancer Epithelial-Specific TRAF3 in Regulating Breast Cancer Cell Survival and Lymphocyte Activity. International Journal of Molecular Sciences. 2026;27(10):4414. doi:10.3390/ijms27104414
BibTeX
@article{Sirinian2026,
author = {Sirinian, Chaido and de Lastic, Anne-Lise and Zaverdas, Harry and Nifora, Martha and Georgakopoulou, Dimitra and Samiotaki, Martina and Argentou, Maria Ioanna and Peroukidis, Stavros and Degn, Søren E and Rusan, Maria and Theofilatos, Konstantinos and Mavroudi, Seferina and Papanastasiou, Anastasios D and Koutras, Angelos},
title = {Dual Role of Cancer Epithelial-Specific TRAF3 in Regulating Breast Cancer Cell Survival and Lymphocyte Activity},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4414},
doi = {10.3390/ijms27104414}
}
EUVIMED